This award is open to UK or European registered emerging biotech companies, with proof of incorporation or commencement of operations on or after 1 Jan 2019 but before 1 June 2022
The questions on the entry form (on the next page) are split across SEVEN key areas:
- Product/Need: Provide an outline and evidence of a credible product pipeline or proof of concept and explain how will you positively impact patients.
- Clinical Trial Activity /Product Development: Please provide evidence of strong progress/success in clinical trials or product development
- Business Plan: Share your robust business plan that supports your long term growth, along with proof of developing partnerships and collaborations, clinical strategy and a regulatory framework
- Story: Share your company 'story' and include examples of your early news flow and a link to company website
- Fundraising: Please provide proof of your continued fundraising and details of your future fundraising strategy
- Team: Provide detail of your management team and board, which should showcase a broad, diverse, and credible team, that exemplifies your Equality, Diversity & Inclusion strategy
- ESG: How are you incorporating Environmental, Social and Governance (ESG) within your everyday business operations
PLEASE NOTE:
- Entries must be submitted via the survey linked on the OBN Awards website – all sections with a * must be completed
- Ensure you adhere to the wordcount guidelines indicated
- You are welcome to enter more than one award category, however content in each entry must be different
- All entries are judged against the criteria outlined in the entry form, with points available as indicated
- Judges will only award points where there is clear proof that each requirement has been met
- Please email events@obn.org.uk for any further questions or clarification about the process.